Pharmaceuticals announced that the U.S. FDA has accepted the New Drug Application for investigational plozasiran for the ...

After much anticipation, a new law has come into effect in Ireland which places significant restrictions on employers when entering ...

The Leinenkugel family still wants to buy the Chippewa Falls site from Molson Coors, despite the latter having allegedly ...

The Phase III trial successfully saw patients achieving clinical remission and stopping rectal bleeding within 28 days.

The FDA has accepted for filing and priority review Sentynl Therapeutics’ CUTX-101 NDA for the treatment of Menkes disease.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

China NMPA has granted acceptance and priority review for the NDA for HUTCHMED’s ORPATHYS (savolitinib) and TAGRISSO (osimertinib) combination ...

The question of whether the DFS is legally binding has been pending in a civil court since 2018. The companies argued, “Despite this, SEBI has opined on matters that are sub-judice. Further, SEBI's ...

Pay the application fee and download a copy of the completed form The UPSC NDA & NA (I) 2025 exam is being conducted to fill 406 vacancies, while the CDS (I) 2025 exam will fill a total of 457 ...

Step 3: Candidates should carefully enter their personal details, academic qualifications, and other details before submitting the form. Step 4: Pay the application fee (if applicable). Step 5: ...

2. Select the link for NDA & NA I 2025 or CDS I 2025 on the homepage. 3. Enter the required registration details and submit them. 4. Log in to the account and fill out the application form.

As the clock ticks down, aspiring candidates for the National Defence Academy (NDA) are reminded that the registration window for the UPSC NDA 1 exam will close tomorrow, December 31. Interested ...